Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer: a large real-life worldwide population

Rimini M, Fornaro L, Rizzato M, Antonuzzo L, Rossari F, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim J, Abidoye O, Rapposelli I, Tamberi S, Finkelmeier F, Giordano G, Nichetti F, Chon H, Braconi C, Pirrone C, Casadei-Gardini A.
European Journal of Cancer. 2024. 114199. ISSN 0959-8049.

Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinoma

Xia C, Krawczyk M, Di C, Krupa Ł, Kruk B, Krawczyk P, Milkiewicz P, Bao H, He X, Liu D, Fan C, Nasser A, Lopens S, Ulrich Weiss F, Frost F, Schierack P, Roggenbuck D, Liu Y
Dig Liver Dis . 2024 Jun 8:S1590-8658(24)00785-0. doi: 10.1016/j.dld.2024.05.027

Strategies to enhance the response of liver cancer to pharmacological treatments

Marin JJG, Macias RIR, Asensio M, Romero MR, Temprano AG, Pereira OR, Jimenez S, Mauriz JL, Di Giacomo S, Avila MA, Efferth T, Briz O.
Am J Physiol Cell Physiol. 2024 May 6. doi: 10.1152/ajpcell.00176.2024.

Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic

Zanuso V, Nash T, Casolino R, Armstrong G, Pallise O, Milne J, Braconi C.
BMC Cancer 24, 597. 2024.

The ABCG8 polymorphism increases the risk of gallbladder cancer in the general population and gallstones in obese patients from Poland.

Krupa L, Kalinowski P, Ligocka J, Dauer M, Jankowski K, Gozdowska J, Kruk B, Milkiewicz P, Zieniewicz K, Krawczyk M, Weber SN, Lammert F, Krawczyk M.
Eur J Clin Invest. 2024; 00:e14213. doi: 10.1111/eci.14213.
Join the Action